Scientists have discovered a hidden mechanism that allows some tumours to change their identity and thus evade treatment. Two new studies have identified key proteins and structures responsible for this ability in tumours. These discoveries help to better understand how cancer cells reprogram themselves to survive. The results suggest that these proteins and structures could be targets for new, specific therapies. The goal is to develop safer and more selective cancer drugs. The studies provide new insights into the mechanisms of tumour resistance to treatment.